Urocortin III explained

Urocortin III, a 38–41 amino acid peptide, is a member of the CRF (corticotropin-releasing factor), also known as CRH (corticotropin-releasing hormone)[1] family of peptides, with a long evolutionary lineage.[2] [3]

Separate chromosomes harboring two exons each are home to the genes encoding UCN, UCN2, and UCN3.[4] A gene on human chromosome 10p15 at location 5.40 Mb encodes the urocortin, UCN III, which has been discovered more recently. A 161 amino acid precursor is produced when the UCN III gene is translated. Mature UCN III with 38 or 41 amino acids would be produced by proteolytic cleavage between arginine- or threonine-lysine residues. Human plasma contains both the 38 and 41 amino acid forms of UCN III, although the 38 amino acid form is more prevalent, according to findings from high-performance liquid chromatography.

Each urocortin peptide has a distinct expression location and function, yet they all share conserved structural similarity. Urocortins' structures, as determined by nuclear magnetic resonance, exhibit alpha-helical secondary structures, which support biological activity and binding selectivity.

Evolutionary view

Multiple urocortin genes are present in vertebrate lineages as a result of the two waves of vertebrate whole-genome duplication. Two ligands, the CRF/UCN1 and UCN2/UCN3 paralogs, and two receptors, CRFR1 and CRFR2, were produced by a first genome duplication in early vertebrates.[5] [6] The CRF system observed in modern vertebrates, which has four ligands and two receptors, was then created by a second genome duplication that split the gene between UCN2 and UCN3 and between CRF and UCN1.[7] Two peptide genes were hypothesized to have been present in a vertebrate progenitor that gave rise to the different lineages that contained urocortin (UCN I), CRH1, and CRH2 in one group and urocortin II (UCN II) and urocortin III (UCN III) in the other.[8]

In many vertebrates, there are five members of the corticotropin-releasing hormone and urocortin family of peptides: CRH (crha/crhb in teleosts), CRH2, UCN/UTS1, UCN II, and UCN III. The two receptors, CRFR1 and CRFR2, and the four ligands, CRF, Urocortin1 (UCN1), UCN2, and UCN3, make up the mammalian CRF system.[9] Genes for mentioned proteins can perform a multitude of tasks in a wide range of animals due to differences in their expression patterns and receptor affinities.

Urocortin affinity to receptors

Compared to UCN II or UCN III, UCN I has a greater binding affinity for the CRHR1 receptor.[10] Urocortin III is extremely selective for the CRF2 receptor, in contrast to Urocortin I and comparable to Urocortin II.[11] Of the two closely related CRF receptors (CRFR1 and CRFR2) that are members of the class B family of G protein-coupled receptors, each peptide activates at least one of them.[12] CRFR2 can be effectively activated by UCN II and UCN III.[13] By attaching itself to CRHR2 with a strong affinity, this peptide (UCNIII) helps regulate a number of bodily processes.[14] All things considered, UCNs have approximately ten times more affinity for CRHR2 than CRH.[15]

Distribution

UCN III is widely distributed throughout the brain and is present in many bodily tissues—including the skin, gastrointestinal tract (GI tract), pancreatic beta cells, kidneys, heart, endocrine system, and brain.[16] The medial amygdala (MeA), rostral perifornical area of the hypothalamus, bed nucleus of the stria terminalis (BNST), superior paraolivary nucleus, nucleus parabrachialis, and premammillary nucleus are the primary locations where UCN III is expressed.

Expression of UCN III occurs late in the differentiation process of beta cells, where it is necessary for complete insulin secretion triggered by glucose and incretin, and is shown in mature beta cells in both mice and humans.[17] Beta cells use the ATP-sensitive potassium channel (KATP channel) to facilitate the glucose-dependent release of UCN III. This is corroborated by the expression of PC1/3, Nkx6.1, and Pdx1 in hESC-derived UCN III + beta cells. But human UCN III is not specific to the beta cell lineage; rather, it is a generic marker for both the alpha and beta cell lineages, as seen by its expression in primary and hESC-derived alpha cells.[18] A universal marker of alpha and beta cell development in humans is Ucn III.

After triggering the receptors in the cerebral endothelial cells, UCN III crosses the blood–brain barrier, as demonstrated by a transneuronal tracer injection into the ventral pre-mammillary nucleus of the rat brain. Further research using tracer molecule injections to examine the function of UCN III reveals that UCN III is located rostral to the hypothalamus and projects to the ventromedial hypothalamus. It is well recognized that this brain region controls energy balance and hunger. In the same brain regions, UCN III and CRHR2 are expressed, and different physiological and behavioral processes result from their activation.[19] [20]

Stress

One important neuropeptide that modulates various aspects of behavior and brain function is UCN III. In the brain, UCN III mRNA was specifically detected in the perifornical region, the medial nucleus of the amygdala, and the median preoptic nucleus.[21] [22] [23] [24]

The endocrine, autonomic, and behavioral reactions to stress are all regulated by the corticotropin-releasing factor (CRF) system, which is widely recognized for this function.[25] When stress levels are elevated, UCN III expression increases. UCN III is mostly expressed in areas linked to stress-related behaviors.[26]

The origin of projection to the midbrain's median amygdala region is the ventral pre-mammillary nucleus, which exhibited high UCN III positivity.[27] The confirmation of UCN III 's essential role in numerous brain activities linked to anxiety, such as aggression and sexual behaviors, comes from its engagement in this circuit.[28] [29] Mammalian stress reactions are known to be modulated by urocortins. It alters mammals' reactions to stress and functions in the stress recovery mechanism. UCN III and its receptor's function in clinical disorders linked to stress,

Stress homeostasis is known to be mediated via a regulatory axis that includes the neuropeptide urocortin III (UCN III) and the corticotropin-releasing hormone receptor 2 (CRHR2). Cardiovascular disease, sleep apnea, post-traumatic stress disorder, and other stress-related health issues are thought to be associated with dysregulation of this peptide/receptor axis. To develop a workable clinical laboratory diagnostic, it is crucial to comprehend the physiology and measurement of the UCN III /CRHR2 axis.

Notes and References

  1. Deussing JM, Chen A . The Corticotropin-Releasing Factor Family: Physiology of the Stress Response . Physiological Reviews . 98 . 4 . 2225–2286 . October 2018 . 30109816 . 10.1152/physrev.00042.2017 . 52008037 . free .
  2. Hsu SY, Hsueh AJ . Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor . Nature Medicine . 7 . 5 . 605–611 . May 2001 . 11329063 . 10.1038/87936 . 22916906 .
  3. Book: Wu V, Yuan PQ, Larauche M, Wang L, Million M . Chapter 183 - Urocortins . January 2013 . Handbook of Biologically Active Peptides . Second . 1346–1353 . Kastin AJ . Boston . Academic Press . 10.1016/b978-0-12-385095-9.00183-4 . 978-0-12-385095-9 .
  4. Squillacioti C, Pelagalli A, Liguori G, Mirabella N . Urocortins in the mammalian endocrine system . Acta Veterinaria Scandinavica . 61 . 1 . 46 . October 2019 . 31585551 . 6778379 . 10.1186/s13028-019-0480-2 . free .
  5. Kuperman Y, Chen A . Urocortins: emerging metabolic and energy homeostasis perspectives . Trends in Endocrinology and Metabolism . 19 . 4 . 122–129 . May 2008 . 18337115 . 10.1016/j.tem.2007.12.002 . 7941033 .
  6. Richard D, Lin Q, Timofeeva E . The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance . European Journal of Pharmacology . 440 . 2–3 . 189–197 . April 2002 . 12007535 . 10.1016/S0014-2999(02)01428-0 . The pharmacotherapy of obesity .
  7. Denver RJ . Structural and functional evolution of vertebrate neuroendocrine stress systems . Annals of the New York Academy of Sciences . 1163 . 1 . 1–16 . April 2009 . 19456324 . 10.1111/j.1749-6632.2009.04433.x . 18786346 . 2009NYASA1163....1D . free . 2027.42/74370 . free .
  8. Bale TL, Vale WW . CRF and CRF receptors: role in stress responsivity and other behaviors . Annual Review of Pharmacology and Toxicology . 44 . 1 . 525–557 . 2004-02-10 . 14744257 . 10.1146/annurev.pharmtox.44.101802.121410 .
  9. Dedic N, Chen A, Deussing JM . The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response . Current Molecular Pharmacology . 11 . 1 . 4–31 . 2018 . 28260504 . 5930453 . 10.2174/1874467210666170302104053 .
  10. Grace CR, Perrin MH, Cantle JP, Vale WW, Rivier JE, Riek R . Common and divergent structural features of a series of corticotropin releasing factor-related peptides . Journal of the American Chemical Society . 129 . 51 . 16102–16114 . December 2007 . 18052377 . 10.1021/ja0760933 .
  11. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW . 6 . Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor . Proceedings of the National Academy of Sciences of the United States of America . 98 . 13 . 7570–7575 . June 2001 . 11416224 . 34709 . 10.1073/pnas.121165198 . free . 2001PNAS...98.7570L .
  12. Li C, Chen P, Vaughan J, Blount A, Chen A, Jamieson PM, Rivier J, Smith MS, Vale W . 6 . Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion . Endocrinology . 144 . 7 . 3216–3224 . July 2003 . 12810578 . 10.1210/en.2002-0087 . free .
  13. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE . 6 . Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors . Proceedings of the National Academy of Sciences of the United States of America . 98 . 5 . 2843–2848 . February 2001 . 11226328 . 30227 . 10.1073/pnas.051626398 . free . 2001PNAS...98.2843R .
  14. Alghamdi NJ, Burns CT, Valdes R . The urocortin peptides: biological relevance and laboratory aspects of UCN3 and its receptor . Critical Reviews in Clinical Laboratory Sciences . 59 . 8 . 573–585 . December 2022 . 35738909 . 10.1080/10408363.2022.2080175 . 249989614 .
  15. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C . 6 . Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor . Nature . 378 . 6554 . 287–292 . November 1995 . 7477349 . 10.1038/378287a0 . 4373077 . 1995Natur.378..287V .
  16. Grone BP, Butler JM, Wayne CR, Maruska KP . Expression patterns and evolution of urocortin and corticotropin-releasing hormone genes in a cichlid fish . The Journal of Comparative Neurology . 529 . 10 . 2596–2619 . July 2021 . 33474732 . 10.1002/cne.25113 . 231665410 .
  17. Li C, Chen P, Vaughan J, Lee KF, Vale W . Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis . Proceedings of the National Academy of Sciences of the United States of America . 104 . 10 . 4206–4211 . March 2007 . 17360501 . 1820733 . 10.1073/pnas.0611641104 . free . 2007PNAS..104.4206L .
  18. van der Meulen T, Xie R, Kelly OG, Vale WW, Sander M, Huising MO . Urocortin 3 marks mature human primary and embryonic stem cell-derived pancreatic alpha and beta cells . PLOS ONE . 7 . 12 . e52181 . 2012-12-14 . 23251699 . 3522648 . 10.1371/journal.pone.0052181 . free . 2012PLoSO...752181V .
  19. Chalmers DT, Lovenberg TW, De Souza EB . Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression . The Journal of Neuroscience . 15 . 10 . 6340–6350 . October 1995 . 7472399 . 6577987 . 10.1523/JNEUROSCI.15-10-06340.1995 .
  20. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE . 6 . Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse . The Journal of Comparative Neurology . 428 . 2 . 191–212 . December 2000 . 11064361 . 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U . 21338401 .
  21. Li C, Vaughan J, Sawchenko PE, Vale WW . Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression . The Journal of Neuroscience . 22 . 3 . 991–1001 . February 2002 . 11826127 . 6758528 . 10.1523/JNEUROSCI.22-03-00991.2002 .
  22. Pan W, Kastin AJ . Urocortin and the brain . Progress in Neurobiology . 84 . 2 . 148–156 . February 2008 . 18078706 . 2267723 . 10.1016/j.pneurobio.2007.10.008 .
  23. Wittmann G, Füzesi T, Liposits Z, Lechan RM, Fekete C . Distribution and axonal projections of neurons coexpressing thyrotropin-releasing hormone and urocortin 3 in the rat brain . The Journal of Comparative Neurology . 517 . 6 . 825–840 . December 2009 . 19844978 . 2849936 . 10.1002/cne.22180 .
  24. Deussing JM, Breu J, Kühne C, Kallnik M, Bunck M, Glasl L, Yen YC, Schmidt MV, Zurmühlen R, Vogl AM, Gailus-Durner V, Fuchs H, Hölter SM, Wotjak CT, Landgraf R, de Angelis MH, Holsboer F, Wurst W . 6 . Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2 . The Journal of Neuroscience . 30 . 27 . 9103–9116 . July 2010 . 20610744 . 6632482 . 10.1523/JNEUROSCI.1049-10.2010 .
  25. Wagner S . Urocortins and their unfolding role in mammalian social behavior . Cell and Tissue Research . 375 . 1 . 133–142 . January 2019 . 30465153 . 10.1007/s00441-018-2962-3 . 53714270 .
  26. Venihaki M, Sakihara S, Subramanian S, Dikkes P, Weninger SC, Liapakis G, Graf T, Majzoub JA . 6 . Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours . Journal of Neuroendocrinology . 16 . 5 . 411–422 . May 2004 . 15117334 . 10.1111/j.1365-2826.2004.01170.x . 8783242 .
  27. Chen P, Lin D, Giesler J, Li C . Identification of urocortin 3 afferent projection to the ventromedial nucleus of the hypothalamus in rat brain . The Journal of Comparative Neurology . 519 . 10 . 2023–2042 . July 2011 . 21452217 . 3694597 . 10.1002/cne.22620 .
  28. Koob GF, Heinrichs SC . A role for corticotropin releasing factor and urocortin in behavioral responses to stressors . Brain Research . 848 . 1–2 . 141–152 . November 1999 . 10612706 . 10.1016/S0006-8993(99)01991-5 . 9724640 .
  29. De Fanti BA, Martínez JA . Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats . Brain Research . 930 . 1–2 . 37–41 . March 2002 . 11879793 . 10.1016/S0006-8993(01)03401-1 . 6034947 . 10171/17847 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Urocortin III".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.